Our Cases

Compass Lexecon has been involved in many of the largest and most complex antitrust litigation and financial market cases over the past 30 years.

Find a Case

Sorry, your search didn't return any results.

05/09/17

Court Tracks Analysis and Testimony of Compass Lexecon Affiliate Professor Robert M. Daines One of AIG's largest shareholders, Starr International Company, Inc. ("Starr") sued the United States, alleging that the Government's acquisition of AIG equity in connection with its bailout...

01/01/16

In recent years, the Securities and Exchange Commission (SEC) has been investigating practices surrounding fees charged in the private equity industry. In this case involving private equity sponsor Thomas H. Lee Partners (THL), the SEC alleged that “monitoring” fees charged...

08/18/15

This case involved Securities and Exchange Commission (SEC) allegations that James Cohen and Joseph Corazzi acted as de facto officers of Natural Blue Resources, Inc. In doing so they were alleged to have orchestrated a fraudulent scheme to control the...

06/22/15

In one of the biggest and most closely watched cases coming out the global financial crisis, Maurice "Hank" Greenberg and Starr International challenged the United States Government's financial rescue of American International Group, Inc. ("AIG") that began in September 2008....

01/07/15

Compass Lexecon was retained by counsel for British Petroleum (BP) to analyze corporate governance issues and the economic implications of the magnitude of BP’s fines under the Clean Water Act (CWA) relating to the Deepwater Horizon oil spill. Compass Lexecon...

11/04/14

In April and May 2014, Valeant made various proposals to acquire Allergan and in June 2014 Valeant launched a tender offer. Entities related to Pershing Square and Valeant purchased approximately 10 percent of the outstanding shares of Valeant prior to...

02/12/14

On February 12, 2014, California State Judge Cormac Carney denied Plaintiff’s motion for preliminary injunction in a suit that claimed that Avanir’s 2014 proxy was materially misleading regarding its proposed equity compensation plan, allowing Avanir, our client, to proceed with...